Ecdysteroids for Health & Longevity - Quick Reference Sheet

Ecdysteroids for Health & Longevity

Created on 07/26/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 Audit

Plant and insect steroid-like compounds, led by ecdysterone, promoted as natural muscle-builders without anabolic-steroid hormone effects. Promise is genuine but unsettled: a purified form modestly preserves mobility and muscle in older adults, while muscle gains in healthy trainees conflict. Early hints for body fat and insulin. Main problems: underdosed products and anti-doping monitoring. (Full Review)

Protocol

Dose
200–1000 mg/day
Verified ecdysterone content, with resistance training
Frequency
2–3× daily
Split doses with food; short half-life
Duration
8–12 week blocks
Time-limited; no taper needed
Time to effect
Strength & Muscle
8–12 weeks
With resistance training
Body Fat & Insulin
12 weeks
At standardized dosing
Acute Effect
None
No felt effect

Benefits

Contraindications
  • Pregnancy or breastfeeding
  • Hormone-sensitive cancers
  • Significant kidney or liver impairment (advanced CKD, eGFR <30 mL/min/1.73m²)
  • Children and adolescents
  • Athletes in tested sport (anti-doping monitored)
Key Interactions
  • Antihypertensives (ACE inhibitors, ARBs)
  • Antidiabetics and insulin (sulfonylureas, metformin)
  • NSAIDs (ibuprofen, naproxen)
  • Stacked performance supplements (creatine, beta-alanine, citrulline malate)

Risk & Side Effects

  • High: [risks_high]
  • Medium: Anti-doping rule violation risk; product mislabeling, contamination, and undeclared anabolic agents
  • Low: Gastrointestinal discomfort
  • Speculative: Exertional rhabdomyolysis when stacked with other supplements; estrogen-receptor-mediated hormonal effects; additive blood-pressure lowering; unknown long-term safety

Monitoring

Marker Target Why
Creatine Kinase (CK) Men ~40–200 U/L; women ~30–150 U/L Detects muscle breakdown (rhabdomyolysis) risk
ALT / AST ALT <25 U/L; AST <25 U/L Screens for liver stress
Creatinine / eGFR eGFR >90 mL/min/1.73m² Screens kidney filtering capacity
Fasting Insulin 2–6 µIU/mL Tracks the insulin-sensitivity benefit signal
HbA1c <5.4% Longer-term glucose control
Estradiol (E2, men) ~20–30 pg/mL Screens for hormonal shifts / possible product contamination
Total Testosterone (men) ~600–900 ng/dL Confirms no unexpected hormonal effect / contamination

Cadence: Safety labs at 8–12 weeks, then every 6–12 months; body composition and performance every 4–8 weeks

Qualitative Assessment

  • Strength progression (bench-press or squat one-repetition maximum trending up)
  • Visible body-composition change (leaner appearance, especially arm and abdominal fat)
  • Training recovery and perceived energy between sessions
  • Absence of new symptoms (dark urine, muscle pain out of proportion to training, dizziness)